FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096180 [Registered on: 17/10/2025] Trial Registered Prospectively
Last Modified On: 17/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Shunti bilwa kashaya and tab doxinate effect in Garbhini Chardi 
Scientific Title of Study   A Randomised Controlled Trial To Evaluate The Efficacy Of Shunthi-Bilwa Kashaya In Garbhini Chardi W.S.R.To Emesis Gravidarum. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR YOGITA KAMLESH YADAV 
Designation  PG Scholar 
Affiliation  Dr G D pol Foundation YMT Ayurvedic Medical College and Hospital 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital, 3rd Floor, Gynaec Dept, Sector- 4, Kharghar , Navi Mumbai

Raigarh
MAHARASHTRA
410210
India 
Phone  8830129423  
Fax    
Email  yogitayadav121@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR JENY BHATT 
Designation  Assistany Professor, PG Guide, PhD (Sch) 
Affiliation  Dr G D pol Foundation YMT Ayurvedic Medical College and Hospital 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital, 3rd Floor, Gynaec Dept, Sector- 4, Kharghar , Navi Mumbai

Raigarh
MAHARASHTRA
410210
India 
Phone  9167541086  
Fax    
Email  dr.jenybhatt@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR YOGITA KAMLESH YADAV 
Designation  PG Scholar 
Affiliation   
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital, 3rd Floor, Gynaec Dept, Sector- 4, Kharghar , Navi Mumbai

Raigarh
MAHARASHTRA
410210
India 
Phone  8830129423  
Fax    
Email  yogitayadav121@gmail.com  
 
Source of Monetary or Material Support  
DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital, Sector- 4, Kharghar , Navi Mumbai 
 
Primary Sponsor  
Name  Dr Yogita Kamlesh Yadav 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College And Hospital, 3rd Floor, Gynaec Dept, Sector- 4, Kharghar , Navi Mumbai 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yogita Kmalesh Yadav  Dr GD Pol Foundation YMT Ayurvedic Medical College and Hospital   3rd Floor, Gynaec Dept, Sector- 4, Kharghar , Navi Mumbai
Raigarh
MAHARASHTRA 
8830129423

yogitayadav121@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Dr G D pol foundation YMT ayurvedic medical college and charitable hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O219||Vomiting of pregnancy, unspecified. Ayurveda Condition: GARBINYA VAMANAVYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: shunthi bilwa kashaya, Reference: yogratnakar stree roga 9/11, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 100(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-Tab Doxinate tab. doxinate ( doxylamine succinate 10mg and pyridoxine 10mg ) orally, for 7 days ,empty stomach OD
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1 Pregnant females diagnosed as garbhini chardi in first trimester of pregnancy of any gravida
2 ANC profile already done by patient 
 
ExclusionCriteria 
Details  1 Hyperemesis Gravidarum
2 Pregnant woman suffering from severe infections such as TORCH etc
3 Pregnant woman suffering from systemic disorders such as DM HTN THYROID etc
4 Pregnant woman on other medications such as Antibiotics Antifungal etc 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To Evaluate and Compare the Efficacy of Shunthi-Bilwa Kashaya and Tablet Doxinate in Garbhini Chardi w.s.r.t. Emesis Gravidarum.  1st Visit - Baseline
2nd Visit - 3rd day
3rd Visit - 7th day
4th Visit 15th day
 
 
Secondary Outcome  
Outcome  TimePoints 
To Study the Complete Literature on Garbhini Chardi & Emesis Gravidarum available in Texts.

 
1st Visit - Baseline
2nd Visit - 3rd day
3rd Visit - 7th day
4th Visit 15th day 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The Present Study is a PG Thesis Topic
By PG Scholar - DR YOGITA KAMLESH YADAV and Guide Name - DR JENY MUKESH BHATT

Title - A RANDOMISED CONTROLLED TRIAL TO EVALUATE THE EFFICACY OF SHUNTHI BILWA KASHAYA IN GARBHINI CHARDI w.s.r.t EMESIS GRAVIDARUM.

According to inclusion and exclusion criteria 
Group A 40 patients  and Group B 40 patients will be selected
Group A ( intervention ) will be given shunthi bilwa kashaya 100ml empty stomach OD for 7 days
Group B ( control/ comparative ) will be given Tab Doxinate 10mg empty stomach OD for 7 days

Total Duration of study is 1 year 6 months. 
 
Close